Scynexis INC Form 4 insider transactions

SCYNEXIS Inc. reports a Form 4 filing detailing director Brian Philippe Tinmouth's acquisition of 2,875 shares and exercise of stock options.

SCYNEXIS Inc. reports a Form 4 filing detailing stock transactions by Director Guy Macdonald.

SCYNEXIS INC reports a Form 4 filing detailing director David C. Hastings' acquisition of common stock and stock options.

SCYNEXIS INC reports a Form 4 filing detailing a director's acquisition of common stock and stock options.

SCYNEXIS Chief Financial Officer Ivor Macleod IV was granted 129,833 restricted stock units, increasing his beneficial ownership.

SCYNEXIS Chief Legal Officer Scott Sukenick was granted 129,833 restricted stock units, vesting over three years starting February 28, 2026.

SCYNEXIS CEO David Angulo Gonzalez received a grant of 391,333 restricted stock units, increasing his beneficial ownership to over 1.2 million shares.

SCYNEXIS CEO David Angulo Gonzalez has established a Rule 10b5-1 plan to acquire 32,500 shares of common stock at $0.76 per share on October 17, 2025.

A recent SEC Form 4 filing reveals SCYNEXIS Director Brian Philippe Tinmouth acquired 23,000 common shares and 23,000 stock options, increasing his beneficial ownership and signaling confidence in the company.

SCYNEXIS Inc. Director Guy Macdonald has acquired 23,000 shares of common stock and 23,000 stock options as part of a compensation grant, increasing his beneficial ownership.

SCYNEXIS Inc. Director David C. Hastings was granted 23,000 shares of common stock and 23,000 stock options, with both vesting on the first anniversary of the grant date, contingent on continuous service.

SCYNEXIS Inc. Director Ann Hanham acquired 23,000 shares of common stock and 23,000 stock options on June 26, 2025, as part of her compensation package.

SCYNEXIS Inc. Director Steven C. Gilman was granted 23,000 shares of common stock and 23,000 stock options, effective June 26, 2025, as part of his compensation package.

SCYNEXIS Inc. Director Armando Anido is set to acquire 23,000 shares of common stock and 23,000 stock options on June 26, 2025, as part of an equity compensation plan.

SCYNEXIS CEO David Angulo Gonzalez purchased 23,000 shares of common stock at an average price of $0.84 on April 9, 2025.

SCYNEXIS CEO David Angulo Gonzalez reports the acquisition of common stock through open market purchases and the employee stock purchase plan.

Scott Sukenick, Chief Legal Officer of SCYNEXIS INC, reports acquiring and disposing of common stock and acquiring employee stock options.

SCYNEXIS Chief Financial Officer Ivor Macleod acquired shares and stock options on January 23, 2025, according to a recent SEC filing.

CEO David Angulo Gonzalez reports acquiring restricted stock units and stock options while disposing of common stock.

SCYNEXIS CEO David Angulo Gonzalez recently purchased 20,000 shares of common stock at an average price of $1.37.

Director Macdonald Guy reports acquisition of 23,000 shares of SCYNEXIS INC and disposal of 55,000 shares.

Director David C Hastings acquired 23,000 shares of common stock and 23,000 stock options in SCYNEXIS INC on June 20, 2024.

Director Steven C Gilman reports acquisition and disposal of SCYNEXIS INC stock and stock options on June 20, 2024.

Director Brian Philippe Tinmouth reports acquiring 23,000 shares of SCYNEXIS INC and disposing of shares, according to a Form 4 filing.

Director Armando Anido acquired 23,000 shares of common stock and 23,000 stock options in SCYNEXIS INC on June 20, 2024.

Director Ann Hanham acquired 23,000 shares of SCYNEXIS INC common stock and options as part of director compensation.